Refine your search
Access to medicines
| Journalist | Outlet & Role | Coverage | Contact | |
|---|---|---|---|---|
FB Market access and medicine availability analysis in pharmaceutical sector | market access pharmaceuticals medicine availability +1 more | |||
AS Anna Smith she Global pharmaceutical market access developments and trends | Contributor NAVLIN DAILY by EVERSANA 940+ | London, England pharmaceutical market access global pharmaceuticals healthcare | ||
AM Night editor with experience in pharmacy and travel clinic journalism | Contributor UNICEPTA UK 1.3K+ | Edinburgh, Scotland pharmacy travel clinic healthcare | ||
IS News, analysis and features in drug regulatory affairs | Edinburgh, Scotland drug regulatory affairs pharmaceuticals healthcare | |||
SS Pharmaceutical industry insights and market outlook content | Contributor India Pharma Outlook | Bengaluru, Karnataka pharmaceuticals healthcare market outlook +1 more | ||
AS Commercial and R&D focus in European pharmaceutical intelligence | Greater London pharmaceuticals commercial research r&d +1 more | |||
MK Pharmaceutical industry intelligence and analysis for global pharma sector | London pharmaceuticals pharma industry global pharma +1 more | |||
DR Pharmaceutical industry content with focus on generics and commercial insights | Southwark, England pharmaceuticals generics commercial insights +1 more | |||
GJ Gemma Jones she Emerging trends in market access and reimbursement | market access reimbursement healthcare +1 more | |||
DS Covers healthcare policy and German drug market from Berlin | Berlin healthcare policy drug market germany +1 more | |||
EC Biopharma news, scientific data interpretation, commercial and scientific analysis | London biopharma scientific data commercial analysis +2 more | |||
WL Pharmaceutical industry content and program contributions | pharmaceuticals healthcare pharma industry | |||
ML Regulatory and commercial implications of pharmaceutical R&D news | Arlington, Virginia pharmaceuticals regulatory affairs drug development +2 more |